If we assume 3 billion base pairs, 1/100,000 transcription errors, but a high rate of intra-transcriptional proofreading, we get that figure down to about 0.3 mutations (wrong letter substitution) per cell division.
DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.
Required fields
© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness
